Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study | SpringerLink
AAD: AbbVie's Skyrizi bests Novartis' Cosentyx in head-to-head psoriasis match | Fierce Pharma
Cosentyx: Package Insert / Prescribing Information - Drugs.com